Polymer implants for intratumoral drug delivery and cancer therapy

Brent D. Weinberg, Elvin Blanco, Jinming Gao

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

To address the need for minimally invasive treatment of unresectable tumors, intratumoral polymer implants have been developed to release a variety of chemotherapeutic agents for the locoregional therapy of cancer. These implants, also termed "polymer millirods," were designed to provide optimal drug release kinetics to improve drug delivery efficiency and antitumor efficacy when treating unresectable tumors. Modeling of drug transport properties in different tissue environments has provided theoretical insights on rational implant design, and several imaging techniques have been established to monitor the local drug concentrations surrounding these implants both ex vivo and in vivo. Preliminary antitumor efficacy and drug distribution studies in a rabbit liver tumor model have shown that these implants can restrict tumor growth in small animal tumors (diameter < 1 cm). In the future, new approaches, such as three-dimensional (3-D) drug distribution modeling and the use of multiple drug-releasing implants, will be used to extend the efficacy of these implants in treating larger tumors more similar to intractable human tumors.

Original languageEnglish (US)
Pages (from-to)1681-1702
Number of pages22
JournalJournal of Pharmaceutical Sciences
Volume97
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Drug Implants
Drug delivery
Tumors
Polymers
Neoplasms
Pharmaceutical Preparations
Drug Design
Therapeutics
Liver
Antineoplastic Agents
Transport properties
Animals
Tissue
Pharmacokinetics
Imaging techniques
Kinetics
Rabbits

Keywords

  • Biodegradable polymers
  • Cancer chemotherapy
  • Controlled release
  • Drug targeting
  • Drug transport
  • Imaging methods
  • Mathematical model

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology

Cite this

Polymer implants for intratumoral drug delivery and cancer therapy. / Weinberg, Brent D.; Blanco, Elvin; Gao, Jinming.

In: Journal of Pharmaceutical Sciences, Vol. 97, No. 5, 05.2008, p. 1681-1702.

Research output: Contribution to journalArticle

Weinberg, Brent D. ; Blanco, Elvin ; Gao, Jinming. / Polymer implants for intratumoral drug delivery and cancer therapy. In: Journal of Pharmaceutical Sciences. 2008 ; Vol. 97, No. 5. pp. 1681-1702.
@article{d45b97ec283e46ae8535cf1f66d36440,
title = "Polymer implants for intratumoral drug delivery and cancer therapy",
abstract = "To address the need for minimally invasive treatment of unresectable tumors, intratumoral polymer implants have been developed to release a variety of chemotherapeutic agents for the locoregional therapy of cancer. These implants, also termed {"}polymer millirods,{"} were designed to provide optimal drug release kinetics to improve drug delivery efficiency and antitumor efficacy when treating unresectable tumors. Modeling of drug transport properties in different tissue environments has provided theoretical insights on rational implant design, and several imaging techniques have been established to monitor the local drug concentrations surrounding these implants both ex vivo and in vivo. Preliminary antitumor efficacy and drug distribution studies in a rabbit liver tumor model have shown that these implants can restrict tumor growth in small animal tumors (diameter < 1 cm). In the future, new approaches, such as three-dimensional (3-D) drug distribution modeling and the use of multiple drug-releasing implants, will be used to extend the efficacy of these implants in treating larger tumors more similar to intractable human tumors.",
keywords = "Biodegradable polymers, Cancer chemotherapy, Controlled release, Drug targeting, Drug transport, Imaging methods, Mathematical model",
author = "Weinberg, {Brent D.} and Elvin Blanco and Jinming Gao",
year = "2008",
month = "5",
doi = "10.1002/jps.21038",
language = "English (US)",
volume = "97",
pages = "1681--1702",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Polymer implants for intratumoral drug delivery and cancer therapy

AU - Weinberg, Brent D.

AU - Blanco, Elvin

AU - Gao, Jinming

PY - 2008/5

Y1 - 2008/5

N2 - To address the need for minimally invasive treatment of unresectable tumors, intratumoral polymer implants have been developed to release a variety of chemotherapeutic agents for the locoregional therapy of cancer. These implants, also termed "polymer millirods," were designed to provide optimal drug release kinetics to improve drug delivery efficiency and antitumor efficacy when treating unresectable tumors. Modeling of drug transport properties in different tissue environments has provided theoretical insights on rational implant design, and several imaging techniques have been established to monitor the local drug concentrations surrounding these implants both ex vivo and in vivo. Preliminary antitumor efficacy and drug distribution studies in a rabbit liver tumor model have shown that these implants can restrict tumor growth in small animal tumors (diameter < 1 cm). In the future, new approaches, such as three-dimensional (3-D) drug distribution modeling and the use of multiple drug-releasing implants, will be used to extend the efficacy of these implants in treating larger tumors more similar to intractable human tumors.

AB - To address the need for minimally invasive treatment of unresectable tumors, intratumoral polymer implants have been developed to release a variety of chemotherapeutic agents for the locoregional therapy of cancer. These implants, also termed "polymer millirods," were designed to provide optimal drug release kinetics to improve drug delivery efficiency and antitumor efficacy when treating unresectable tumors. Modeling of drug transport properties in different tissue environments has provided theoretical insights on rational implant design, and several imaging techniques have been established to monitor the local drug concentrations surrounding these implants both ex vivo and in vivo. Preliminary antitumor efficacy and drug distribution studies in a rabbit liver tumor model have shown that these implants can restrict tumor growth in small animal tumors (diameter < 1 cm). In the future, new approaches, such as three-dimensional (3-D) drug distribution modeling and the use of multiple drug-releasing implants, will be used to extend the efficacy of these implants in treating larger tumors more similar to intractable human tumors.

KW - Biodegradable polymers

KW - Cancer chemotherapy

KW - Controlled release

KW - Drug targeting

KW - Drug transport

KW - Imaging methods

KW - Mathematical model

UR - http://www.scopus.com/inward/record.url?scp=48549107173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48549107173&partnerID=8YFLogxK

U2 - 10.1002/jps.21038

DO - 10.1002/jps.21038

M3 - Article

C2 - 17847077

AN - SCOPUS:48549107173

VL - 97

SP - 1681

EP - 1702

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 5

ER -